OraSure Technologies Announces Third Quarter 2026 Financial Results
OraSure Technologies reported its financial results for the third quarter ended September 30, 2026, highlighting 14% year-over-year revenue growth and improved gross margins.
Stocks · News reference
OraSure Technologies Q3 Adj. EPS $(0.15) Beats $(0.20) Estimate, Sales $30.907M Miss $31.021M Estimate
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
OraSure Technologies Q3 2026 Earnings Call Transcript
OraSure Technologies (NASDAQ:OSUR) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
OraSure Technologies Sees FY2026 Sales $120.427M vs $121.304M Est
OraSure Technologies Sees Q4 Sales $30.000M-$32.000M vs $31.701M Est
OraSure Technologies Joins World Coalition on Sickle Cell Disease
OraSure Technologies has joined the World Coalition on Sickle Cell Disease, an international public-private partnership focused on improving global care and early diagnosis for patients with the condition.
OraSure Technologies rejoint la Coalition mondiale contre la drépanocytose afin de favoriser l’accès à un diagnostic plus précoce et aux soins
OraSure Technologies has joined the World Coalition on Sickle Cell Disease, a public-private international partnership aimed at strengthening the global fight against sickle cell disease. As a member, OraSure will contribute diagnostic expertise to support early diagnosis, screening, and improved healthcare system capacity to address patient needs in various healthcare settings.